| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |